| Structure | Chemical Name | CAS | MF |
|
N-(sec-butyl)-5-(hydrazinocarbonyl)-1-methyl-1H-pyrrole-3-sulfonamide
|
|
|
|
|
N-(sec-butyl)-2-{4-[(3E)-3-(hydroxyimino)butyl]phenoxy}acetamide
|
|
|
|
|
N-(sec-butyl)piperidine-3-sulfonamide
|
|
|
|
|
N-(sec-butyl)-2-(2-cyanophenoxy)acetamide
|
|
|
|
|
N-(sec-butyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
|
|
|
|
|
N~2~-(sec-butyl)pyridine-2,5-diamine
|
|
|
|
N-(SEC-BUTYL)-3-PHENYLPROP-2-YN-1-AMINE
|
889949-75-1
|
C13H17N
|
|
N1-(sec-Butyl)-N3-methyl-1,3-propanediamine
|
|
C8H20N2
|
|
N-{2-[2-(sec-Butyl)phenoxy]ethyl}-3-(2-phenoxyethoxy)aniline
|
|
C26H31NO3
|
|
N-[4-(sec-Butoxy)benzyl]-4-(isopentyloxy)aniline
|
|
C22H31NO2
|
|
|
N'-{2-[2-(sec-butyl)phenoxy]acetyl}-4-nitrobenzohydrazide
|
|
C19H21N3O5
|
|
|
N-(sec-butyl)-3-ethoxybenzamide
|
|
C13H19NO2
|
|
N-(SEC-BUTYL)-N-[(6-CHLOROIMIDAZO[2,1-B][1,3]THIAZOL-5-YL)METHYLENE]AMINE
|
|
C10H12ClN3S
|
|
N-(4-SEC-BUTYL-PHENYL)-2-CYANO-ACETAMIDE
|
|
C13H16N2O
|
|
N-[4-(SEC-BUTYL)PHENYL]-2-[4-(4-NITROPHENYL)PIPERAZINO]ACETAMIDE
|
|
C22H28N4O3
|
|
N-(SEC-BUTYL)THIENO[3,2-B][1]BENZOTHIOPHENE-2-CARBOXAMIDE
|
|
C15H15NOS2
|
|
|
NR1 NMDA receptor
|
|
|
|
|
NR1 (NMDA Receptor, N-methyl-D-aspartate)
|
|
|
|
N-SEC-OCTYL-N'-PHENYL-P-PHENYLENDIAMINE
|
|
C20H28N2
|
|
|
N-[[(1R)-Octahydro-2H-quinolizin]-1-ylmethyl]-2,2,2-trifluoroacetamide
|
|
|
|
|
N-[[(1R)-Octahydro-2H-quinolizin]-1-ylmethyl]-2-chloroacetamide
|
|
|
|
|
N-[[(1R)-Octahydro-2H-quinolizin]-1-ylmethyl]phthalimide
|
|
|
|
|
N-[[(2R)-1-Octylpyrrolidin-2β-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
|
|
(-)-N-[(S)-1-Cyano-2-methylpropyl]benzamide
|
|
|
|
|
N-[(αS)-α-Cyanobenzyl]-4-methylbenzenesulfonamide
|
|
|
|
|
(-)-N-[(S)-4-Cyano-α-methylbenzyl]acetamide
|
|
|
|
|
(-)-N-[(S)-1-Cyanoethyl]acetamide
|
|
|
|
|
(-)-N-[(S)-α-Cyano-4-acetyloxy-3-methoxy-α-methylphenethyl]acetamide
|
|
|
|
|
(-)-N-[(S)-6-Cyano-3-methylhexyl]acetamide
|
|
|
|
|
N-[(S)-α-Cyanobenzyl]carbamic acid benzyl ester
|
|
|
|
|
(-)-N-[(S)-α-Cyano-4-hydroxy-3-methoxy-α-methylphenethyl]acetamide
|
|
|
|
|
(+)-N-[(S)-3-Cyano-1-methyl-3,3-diphenylpropyl]-N-methylformamide
|
|
|
|
|
N-[[[(5S)-7α-Cyano-6,7,9,10,13,14,14aα,15-octahydro-1,4,5α-triacetoxy-2,11-dimethoxy-3,12,16-trimethyl-10,13-dioxo-6α,15α-epimino-5H-isoquino[3,2-b][3]benzazocin]-9β-yl]methyl]-2-oxopropionamide
|
|
|
|
|
(+)-N-[(S)-α-Cyanobenzyl]acetamide
|
|
|
|
|
N-[[(3S)-6-Cyano-3,4-dihydro-3β-hydroxy-2,2-dimethyl-2H-1-benzopyran]-4-yl]carbamic acid ethyl ester
|
|
|
|
Boc-L-Val-nitrile
|
216319-90-3
|
C10H18N2O2
|
|
|
(+)-N-[(S)-1-Cyclohexylethyl]phthalimide
|
|
|
|
|
N-[(1S)-1-[[[Cyclopentyl][[[1-(trifluoroacetyl)-2-methylpropyl]carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide
|
|
|
|
|
(+)-N-[(S)-2-Cyclohexyl-1-methylethyl]-2-methylenesuccinimide
|
|
|
|
|
(+)-N-[(S)-2-Cyclohexyl-1-methylethyl]maleimide
|
|
|
|
|
(-)-N-[(S)-1-Cyclohexyl-2-(acetyloxy)ethyl]benzamide
|
|
|
|
|
(+)-N-[(S)-1-Cyclohexyl-2-benzoyloxyethyl]dibenzoylamine
|
|
|
|
|
(-)-N-[(S)-1-Cyclohexyl-2-acetyloxyethyl]acetamide
|
|
|
|
|
(-)-N-[(S)-1-Cyclohexylethyl]-2-methylenesuccinimide
|
|
|
|
|
N-[(1S)-1-[[[Cyclooctyl][[[1-(trifluoroacetyl)-2-methylpropyl]carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide
|
|
|
|
|
N-[(1S)-1-Cyclohexylethyl]maleimide
|
|
|
|
|
(-)-N-[(S)-1-Cyclohexyl-2-hydroxyethyl]benzamide
|
|
|
|
|
(+)-N-[(S)-2-Cyclohexyl-1-methylethyl]benzamide
|
|
|
|
|
(+)-N-[(S)-1-Cyclohexylethyl]benzamide
|
|
|
|
|
(-)-N-[(S)-1-Cyclohexylethyl]acetamide
|
|
|
|
|
(-)-N-[(S)-1-Cyclohexyl-2-hydroxyethyl]acetamide
|
|
|
|
|
N-[(S)-2-[[[(Dodecanoyl)amino]acetyl]amino]-5-methylhexanoyl]-L-valine methyl ester
|
|
|
|
|
N-[[(2S)-1-Dodecylpyrrolidin-2α-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
|
|
nRNP
|
|
|
|
|
N-[[(2R)-1-Nonylpyrrolidin-2β-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
|
|
NSE, Gamma-Enolase
|
|
|
|
|
NSD3 protein
|
|
|
|
|
NSD1 protein
|
|
|
|
|
(+)-N-[(R)-p-Amino-α-methylbenzyl]phthalimide
|
|
|
|
|
NSF Antibody
|
|
|
|
|
NSF Antibody 1
|
|
|
|
|
(+)-N-[(R)-p-Bromo-α-methylbenzyl]phthalimide
|
|
|
|
|
NSE Mouse Monoclonal
|
|
|
|
|
NSE (Neuron specific Enolase)
|
|
|
|
|
(+)-N-[2-[[(R)-1-O,2-O-Dipalmitoyl-L-glycero-3-phospho]oxy]ethyl]phthalimide
|
|
|
|
|
(+)-N-[2-[[(R)-1-O,2-O-Dimyristoyl-L-glycero-3-phospho]oxy]ethyl]acetamide
|
|
|
|
|
(-)-N-[2-[(R)-1-O,2-O-Dioctadecyl-L-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
|
(+)-N-[2-[(R)-1-O,2-O-Dimyristoyl-L-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
|
(+)-N-[2-[(R)-1-O,2-O-Dipalmitoyl-L-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
|
(-)-N-[2-[(R)-1-O,2-O-Dihexadecyl-L-glycero-3-phospho]ethyl]phthalimide
|
|
|
|
|
N-[(R)-1-(Pentachlorophenyl)-2-methyl-2-propenyl]-4-methylbenzenesulfonamide
|
|
|
|
|
NSEP-1 protein
|
|
|
|
|
N4SE protocol
|
|
|
|
N-[(1R)-1-PHENYLETHYL]-8-THIEN-3-YL-1,6-NAPHTHYRIDINE-2-CARBOXAMIDE
|
|
C21H17N3OS
|
|
N-[(R)-(+)-1-PHENYLETHYL]IMIDAZOLE-1-CARBOXAMIDE
|
1217846-28-0
|
C12H13N3O
|
|
|
N-[(1R)-1-Phenylethyl]-1-phenylethylideneamine
|
|
|
|
|
N-[(R)-1-Phenyl-2-hydroxyethyl]benzamide
|
|
|
|
|
N-[(R)-1-Phenylheptan-3-yl]acetamide
|
|
|
|
|
N-[(1R)-1-Phenylethyl]-4-methylbenzenesulfonamide
|
|
|
|
|
N-[(1R)-1-Phenyl-2-chloroethyl]benzamide
|
|
|
|
|
(-)-N-[(R)-α-Phenacylbenzyl]benzamide
|
|
|
|
|
N-[(R)-4-Phenylbutan-2-yl]carbamic acid methyl ester
|
|
|
|
|
N-[(1R)-1-Phenylethyl](2-pyridyl)methanimine
|
|
|
|
|
(-)-N-[(R)-1-(4-Phenyl-2-thiazolyl)ethyl]benzamide
|
|
|
|
|
(-)-N-[(R)-α-Phenylphenacyl]formamide
|
|
|
|
|
N-[(R)-1-Phenylbutan-2-yl]adenosine
|
|
|
|
|
N-[(R)-1-Phenylheptan-3-yl]carbamic acid methyl ester
|
|
|
|
|
N-[(R)-1-Phenylethyl]carbamic acid (E)-3-cyclohexylallyl ester
|
|
|
|
N-Serinyl-S-acetylcysteamine trifluoroacetate
|
147529-77-9
|
|
|
|
N-26 SEQUENCING PRIMER
|
|
|
|
|
NR1, phosphorylated (Ser897) (NMDA Receptor, N-methyl-D-aspartate)
|
|
|
|
|
NR1, phosphorylated, Antibody Kit, BioAssay (NMDA Receptor, N-methyl-D-aspartate)
|
|
|
|
|
NR1, phosphorylated (Ser896) (NMDA Receptor, N-methyl-D-aspartate)
|
|
|
|
|
N-[(2S,3E,5S)-2-Isopropyl-5-[(tert-butoxycarbonyl)amino]-1-oxo-3-hexenyl]-L-phenylalanine methyl ester
|
|
|
|
|
(-)-N-[(R)-4-Phthalimidyl-2-(p-tolylsulfonylamino)butyryl]glycine ethyl ester
|
|
|
|
N-[1-(S)-ERTHOXYCARBONYL-3-PHENYLPROPYL]-L-ALANINE
|
|
C15H21NO4
|
|
|
Nse2 (Smc5-6)
|
|
|
|
N-Seryl-N'-(2,3,4-trihydroxybenzyl)hydrazine
|
26652-10-8
|
|
|
|
(+)-N-[(R)-p-Iodo-α-methylbenzyl]phthalimide
|
|
|
|
|
N-[[(2R)-Piperidin-2-yl]carbonyl]-L-Leu-Gly-NH2
|
|
|